C ervical cancer continues to be a major cause of morbidity and mortality among the female population worldwide, representing the second most common cancer in females with 500 000 news case e es and 280 000 deaths each year. 1e3 In underdeveloped countries such as Latin America and Southeast Asia it is considered the leading cause of cancer mortality in women. 1e3 Since the introduction of the Pap smear in the 1940s, the incidence of cervical cancer has dropped drae e matically, especially in countries with welleestablished cervical screening programs such as the USA where it is considered the sixth most common cancer in women with 13 000 cases of invasive carcinomas and 55 000 cases of carcinoma in situ diagnosed annually. 4 In Saudi Arabia, cervical cancer ranks as the eighth most common cancer in females with a mean age of 53 years. 5 Standardization of Pap smear reporting using the Bethesda system 10 unified various overlapping termie e nologies and hence improved the diagnosis and managee e ment of these lesions. Reports describing the frequency and pattern of abnormal Pap smears in developing countries, particularly Saudi Arabia, using the revised Bethesda system are very few. For this reason the current study was conducted to explore the pattern of epithelial cell abnormalities detected in Pap smears in females of the western region of Saudi Arabia using the Bethesda system and to correlate the findings with published nae e tional and international data, in an effort to help ime e prove the utilization of the Pap smear as a screening tool for cervical cancer in our region.
METHODS
We conducted a computerized data retrieval of all cervie e cal Pap smears reported in the department of Pathology of King Abdulaziz Medical City, Jeddah, a large tertiary hospital and oncology referral centre in the western ree e gion of Saudi Arabia, in the period from the beginning of January 1998 to the end of August 2005. Adequate smears were first identified. A smear was considered adequate when all needed clinical information was present, including appropriate labeling of the slide, adee e quate sampling of the transformation zone and optimal preservation of the slide. All adequate cervical cytology smears were reviewed and reclassified according to the revised 2001 Bethesda system of Pap smear reporting (Table 1) , into negative for intraepithelial lesions or mae e lignancy or positive for epithelial abnormalities. Under the category of negative for intraepithelial lesions or malignancy the number and percentage of unremarke e able (negative) smears and smears showing inflammae e tory/reactive smears were identified. Smears positive for epithelial cell abnormalities were identified and fure e ther classified following the 2001 Bethesda system. In cases of ambiguous diagnoses, the cytology slides were retrieved and reviewed on a multihead microscope by a senior cytotechnoogist and a cytopathologist especially assigned to review these cases using the above mene e tioned system. The total number and percentages of each abnormal Pap smear category were identified and correlated with the patient' s age.
RESULTS
In the computer database we identified a total of 5746 cervical pap smears received and reported in the Department Of Pathology at King Abdulaziz Medical City (KAMC), Jeddah, in the period from January 1998 to August 2005. The study identified 5590 (97.2%) sufe e ficient smears and 156 (2.8%) insufficient smears. The latter cases were excluded from this study. Of the 5590 sufficient smears, 4304 (77%) smears were reported as negative for squamous epithelial abnormalities while 1025 (18%) showed inflammatory/reactive changes ( Figure 1 ). Two hundred sixtyeone smears (5%) were diagnosed as positive for cervical epithelial abnormalie e ties. The positive smears were further classified accorde e ing to the revised 2001 Bethesda system as shown in Figure 2 and Table 2 . No endocervical or endometrial cells, favor neoplastic or adenocarcinoma in situ were reported in this study.
DiScUSSion
In Saudi Arabia, cervical carcinoma ranks as the eighth most common cancer accounting for 3.6% of all cane e cers in females, with a mean age of 53 years. 5 Although many risk factors has been studied as etiologic factors leading to cervical cancer, recently published internae e tional epidemiologic and molecular studies confirm beyond a doubt the strong casual relationship between human papilloma virus (HPV) and cervical intraepie e thelial lesions and carcinoma independent of other risk factors. 6 The WHO has concluded that there is suffie e cient evidence to consider HPV as the cause of cervical cancer. 7 Over 100 HPV types have been isolated with more than 15 considered oncogenic (such as type 16, 18, 31, 33, 35, and others) based on their association with malignant lesions. 8 Over the years, the original Pap smear classificae e tion system has gone through many modifications in response to our growing knowledge of cervical carcie e noma precursors and our understanding of the rule of HPV cervical carcinogenesis. These overlapping clase e sifications contain several vague terminologies. Poorly defined abnormal smear findings have pushed the medical societies to try to unify different reporting syse e tems. 9 In 1988, the National Cancer Institute adopted the Bethesda system for cervical smear reporting 10 in an attempt to overcome this problem. This system undere e went further updates later in 1991.
11 In the year 2001, a revised Bethesda system was introduced 12 to include new technologies such as HPV DNA studies and liqe e uid base cytology. The adequate but limited category in the adequacy component was cancelled and the atypical squamous cells of undetermined significance (ASCUS) category is divided into either atypical squamous cells of undetermined significance (ASCeUS) or atypical squae e mous cells where high grade cannot be ruled out (ASCe H). 12 The United Atates and many other countries use the revised Bethesda classification for both squamous and glandular lesions.
Few reports are present from our region studying the prevalence of cervical cancer and its precursors use e ing the newly revised 2001 Bethesda system. In this study, all abnormal Pap smears received and reported by the pathology department in King Abdulaziz Medical City, Jeddah were retrieved and reclassified following the Bethesda system. Smears studied in this report are of Saudi females since our centre is a strict military and referral hospital for local citizens only. Our results are in agreement with previously published studies from this country, 13e16 showing a lower incidence of abnormal cervical lesions and a wider age range when compared with those from other countries. 17e19 In a previous study from the same hospital, 13 97 of 3088 Pap smears were reported as abnormal over a period of 7 years. In that study, the findings were as follows: ASCeUS (0.45%), LSIL (0.93%), HSIL (0.55%), invasive squamous cell carcinoma (0.13%), AGUS (0.13%), and adenocarcie e noma (0.03%).
The percentages of low SIL, High SIL and AGUS categories in the present as well as the above mentioned study from the same hospital were similar, except for a decrease in the percentage in the ASC category (1.84% for ASCeUS and 0.1% for ASCeH) and an increase in the incidence of both invasive squamous cell carcinoe e ma (0.37% in the present study) and adenocarcinoma (0.25% in the present study).
Although it may be due to the natural progression of this disease, the increase in the total number of Pap smears with an increased incidence in certain categories and a decreased incidence in borderline categories such as ASCeUS is most likely due to the increased rate of referred cancer cases to the recently opened oncology referral centre (opened in the year 2000), the increased awareness of Saudi females of the importance of cervie e cal cancer screening and abidance of cytotechnoogists and cytopathologists to more stringent criteria when submitting diagnoses such as ASCeUS.
Edelman et al 17 studied Pap smears from 29 295 fee e males over a period of one year and the Pap smear abe e normalities were as follows: 9.9% ASCeUS, 2.5% LSIL, 0.6% HSIL and 0.2% invasive cancer. In the same study adolescents with an age range of 13e22 years had a sige e nificantly higher rate of LGSIL (lowegrade squamous . The compared to the present study, a comparable number of HGSIL (highegrade squamous intraepithelial lesion) and low number of invasive carcinoma could be related to early detection of abnormal cervical lesions by well established cervical screening programs. In another study from Brazil 18 22 441 Pap smears were examined over a period of 5 years (October 1997eOctober 2002) and results showed that lowegrade lesions were more common in women aged 15e30 years while highegrade lesions were more come e mon in women aged 25e45 years. Patients older than 40 years had the greatest incidence of invasive cancer. Although a similar age range difference between lowe and highegrade lesions is seen in the present study cone e firming the welleestablished natural history of cervical carcinogenesis, all grades of abnormal cervical lesions were seen in slightly older age groups when compared to the two previous studies, most likely due to late dee e tection of such lesions, usually as a part of either post partum follow up or investigation of a gynecologic come e plaint.
In our study, The ASCeUS category accounted for 40% of all abnormal smears, ASCeH for 2% of all abe e normal cases and the atypical glandular cell diagnosis (AGC) including AGUS, NOS as well as atypical ene e docervical and endometrial cells (NOS) for a total of 11% which compares favorably with other local 13e16 and international figures. 19 Table 2 . numbers and percentages of epithelial abnormalities out of the total number of smears (5590) and total number of positive smears (261), including age range and average age using the revised 2001 bethesda System.
In the last decade several new techniques have been developed such as thinelayer cytological preparations and hybrid capture testing for HPV DNA. 21, 22 Thin prep cytology, approved by the FDA in 1996, is based on collection of the cervical cell sample in a vial containe e ing a special liquid media. Several studies 22 showed that the thin prep method of sampling results in a signifie e cant increase in cytological diagnosis of cervical smear precursors and in an increased percentage of adequate smears as compared with the conventional method of Pap smearing. Although clear recommendations for the use of HPV DNA testing in cervical cancer screening are still not available and data is still insufficient to juse e tify the use of HPV DNA testing as a primary methe e od of cervical cancer screening, the cost effectiveness as well as ability to incorporate the value of a positive HPV test into the management of the screened patient should be studied. 21 In one study by Kaufman et al 23 1128 women with two readings of either LGSIL or ASCUS on Pap smear received colposcopy, biopsy and HPV DNA testing. The detection of higherisk DNA HPV poorly predicted the likelihood of finding CIN 2 or 3 on biopsy. The sensitivity of HPV testing was only 28% for women with ASCUS and only 58% for women with LGSIL. In June 2006, the FDA 24 approved Gardasil, a vaccine targeted against HPV type 6 and 11 which ace e counts for 90% of genital warts and HPV type 16 and 18, which accounts for 70% of cervical cancer. Whether the vaccine can be used effectively in prevention of cervie e cal cancer in this country is yet to be determined. More research is needed to unmask the definite etiological factors for cervical cancer and whether a causeeeffect relationship between HPV and cervical intraepithelial lesions and cancer can be established in our country.
Based on the data regarding the incidence of abnore e mal cervical lesions outlined in the present as well as the previously published local studies and reports, 13e16 health and social organizations in this country should coopere e ate to build a welleorganized national cervical screening program. Key elements for the establishment and suce e cess of such a program include increased public awaree e ness, especially in young females about the importance of cervical screening in prevention of cervical cancer, the availability of financial coverage as well as standardizae e tion of protocols used in diagnosis and management of these lesions by health professionals. It is recommende e ed that different parties including gynecologists, fame e ily physicians and midwives as well active community members initiate such programs. These parties should be aware and work hard to overcome several obstacles that may be faced during the implementation of such programs such as poor education among females from rural areas and small villages as well as the presence of some cultural restraints in those places which prohibit full access to the target groups of the population.
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